Skip to content
CancerIndex

Publication

PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer.

Caner Civan, Madeleine J Karpinski, Christopher Darr, Thanusiah Selvamoorthy, Lisa Marie Rennau, Sebastian Hoberück, Matthias Miederer, Tobias Hölscher, Martin Bögemann, Michael Schäfers, Isabel Rauscher, Osman Güven, Jeremie Calais, Koichiro Kimura, Dominic Ufton, Marcin Miszczyk, Michael S Hofman, Thomas A Hope, Claudia Kesch, Ken Herrmann, Boris Hadaschik, Matthias Eiber, Wolfgang P Fendler, Kambiz Rahbar

European urology focusSep 9, 2026PMID 42716860doi:10.1016/j.euf.2026.06.006 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 11, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260911-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND AND OBJECTIVE: Prostate-specific membrane-antigen positron emission tomography (PSMA-PET) detects distant metastases in more than half of patients with increasing prostate-specific antigen despite castrate levels of testosterone and high-risk nonmetastatic disease on conventional…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.